…iling of the NSCLC TME reveals key prognostic markers linked to immunotherapy response. We present a scalable framework for spatial biomarker…
immunotherapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning immunotherapy
241 articles · page 4 of 21…and (3) IFN-γ gene profiling for ambiguous cases—can streamline immunotherapy selection, enhance precision, and eliminate unnecessary spendin…
…rdal A. Model of patient-specific immune-enhanced organoids for immunotherapy screening: feasibility study. Annals of Surgical Oncology 2020;…
…erative for the development of innovative strategies to augment immunotherapy efficacy in GBM.Acknowledgements We acknowledge TME Pharma AG f…
…s with higher Akk abundance showed better clinical responses to immunotherapy. The phase I trial (N=20) demonstrated favorable safety: 70% (1…
…s with higher Akk abundance showed better clinical responses to immunotherapy. The phase I trial (N = 22) demonstrated favorable safety: 86% …
…e administration of first-line chemotherapy in conjunction with immunotherapy. At first recurrence, the patient received H101 injection in me…
… 8 our device could enable a ‘continuous biopsy’ of response to immunotherapy.Acknowledgements This work was supported the Office of the Dire…
… in navigating these complex treatment choices.We conclude that immunotherapy and targeted agents have irrevocably altered curative-intent NS…
…cellular carcinoma (HCC) and the complex symptom profile during immunotherapy, the effectiveness and implementation of ePROs-based interventi…
…ia that inhibit colorectal cancer (CRC) progression and enhance immunotherapy efficacy.Design The abundance of bacteria in CRC patients was e…
…une microenvironment and enhancing the efficacy of conventional immunotherapy. Collectively, this perspective outlines evolving strategies in…